Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
Operating Expenses | 3,149 | 3,688 | 3,142 | 2,650 | 4,082 |
Operating Income | -3,149 | -3,689 | -3,142 | -2,650 | -4,082 |
Interest Expense | 5 | 5 | 6 | 0 | 5 |
Other Income | 24 | 58 | 46 | 1,190 | 1,715 |
Pre-tax Income | -3,130 | -3,635 | -3,102 | -1,460 | -2,372 |
Net Income Continuous | -3,130 | -3,635 | -3,102 | -3,832 | -2,372 |
Net Income | $-3,130 | $-3,635 | $-3,102 | $-3,832 | $-2,372 |
EPS Basic Total Ops | -92.75 | -119.25 | -122.57 | -188.82 | -115.94 |
EPS Basic Continuous Ops | -91.18 | -117.65 | -123.63 | -188.77 | -117.32 |
EPS Diluted Total Ops | -92.75 | -119.25 | -122.57 | -188.82 | -115.94 |
EPS Diluted Continuous Ops | -91.18 | -117.65 | -123.63 | -188.77 | -117.32 |
EBITDA(a) | $-3,090 | $-3,630 | $-3,084 | $-2,569 | $-4,031 |